Overall Technical outlook

Price Summary

On 2026-02-02, Zydus Lifesciences Limited's shares started at 876.3, peaked at 882.0, bottomed out at 863.65, and ended 0.38% up at 879.65, with 405624 shares traded.
The highest price the stock achieved in the past 52 weeks is 1047.85, while the lowest price it saw is 822.1.
The price outlook for ZYDUSLIFE is between 850.0 and 1255.0, with an average expectation of 1015.73334, as estimated by 30 analysts.

Technicals


Aroon: The AROON is in a neutral stance, with no clear direction indicated for the market. This lack of clarity suggests that the market may be in a state of equilibrium for ZYDUSLIFE, with no strong trend emerging.
ZYDUSLIFE aroon 91794a
Aroon chart for Zydus Lifesciences Limited


Bol. Bands: The BOLL BANDS is in a neutral stance, with no clear direction indicated for the market. This lack of clarity suggests that the market may be in a state of equilibrium for ZYDUSLIFE, with no strong trend emerging.
ZYDUSLIFE bbands 91794a
Bolinger Bands chart for Zydus Lifesciences Limited


Parabolic SAR: The PSAR continues to indicate a bullish outlook, establishing a key support level that could sustain the market's upward trend. This support suggests that the bullish momentum is likely to persist, offering a foundation for further growth.
ZYDUSLIFE psar 91794a
Parabolic Stop and Reverse chart for Zydus Lifesciences Limited


Stochastic: The STOCHASTIC is in a neutral stance, not pointing to a clear trend in either direction. This suggests that the market may be lacking strong momentum, making it difficult to predict the next move.
ZYDUSLIFE stoch 91794a
Stochastic chart for Zydus Lifesciences Limited


Tripple Moving Agerage: The alignment of the 20-50-100 period moving averages supports a bullish trend, yet the slopes of the shorter-term averages suggest a possible weakening. The faster averages indicate that a reversal might be approaching, with the upward momentum potentially losing steam. This could signal an upcoming change in direction.
ZYDUSLIFE trippleSMA 91794a
Tripple SMA chart for Zydus Lifesciences Limited


To derive valuable insights from a company's technical performance, it is essential to first understand its fundamentals. This includes its financial health, business model, and market share. Equally important is the industry context, such as competition, consumer demand, and market trends. By examining these aspects together, investors can gain a more comprehensive view of how the company's stock behaves and whether it's aligned with its underlying value.